Egalet (EGLT) Announces Positive Top-Line Data for OXAYDO vs Roxicodone
Tweet Send to a Friend
Egalet Corporation (Nasdaq: EGLT) announced top-line results from a pharmacokinetic study demonstrating bioequivalence (BE) of OXAYDO (oxycodone HCl, USP) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE